Literature DB >> 19019936

Recovery of corneal irregular astigmatism, ocular higher-order aberrations, and contrast sensitivity after discontinuation of overnight orthokeratology.

T Hiraoka1, C Okamoto, Y Ishii, F Okamoto, T Oshika.   

Abstract

AIMS: To examine prospectively the recovery of various parameters after discontinuation of overnight orthokeratology.
METHODS: Seventeen subjects undergoing orthokeratology for 12 months were examined. Refraction, corneal topography, wavefront aberrometry, a visual acuity test and a contrast sensitivity test were performed at baseline, 12 months after commencement of the procedure, and 1 week and 1 month after discontinuation of the treatment. Asymmetry and higher-order irregularity components were calculated using a Fourier analysis of the corneal topography data. Contrast sensitivity was assessed at four spatial frequencies, and the area under the log contrast sensitivity function (AULCSF) was calculated.
RESULTS: Orthokeratology significantly reduced manifest refraction (p<0.0001, Dunnett test) and significantly improved uncorrected visual acuity (UCVA) at 12 months after commencement of the procedure (p<0.0001). Asymmetry and higher-order irregularity components increased significantly (p<0.0001, p = 0.0032, respectively), and third- and fourth-order aberrations also increased significantly (p<0.0001). The treatment resulted in significant decreases in AULCSF (p = 0.0004). After discontinuing lens wear, all parameters, such as refraction, UCVA, asymmetry, higher-order irregularity, third-order aberration, fourth-order aberration and AULCSF, returned to the baseline level at 1 week.
CONCLUSION: This study confirmed that the effect of orthokeratology is completely reversible in light of optical quality of the eye and quality of vision as well as refraction and visual acuity.

Entities:  

Mesh:

Year:  2008        PMID: 19019936     DOI: 10.1136/bjo.2007.136655

Source DB:  PubMed          Journal:  Br J Ophthalmol        ISSN: 0007-1161            Impact factor:   4.638


  8 in total

1.  A machine learning-based algorithm used to estimate the physiological elongation of ocular axial length in myopic children.

Authors:  Tao Tang; Zekuan Yu; Qiong Xu; Zisu Peng; Yuzhuo Fan; Kai Wang; Qiushi Ren; Jia Qu; Mingwei Zhao
Journal:  Eye Vis (Lond)       Date:  2020-10-22

2.  Overnight orthokeratology is comparable with atropine in controlling myopia.

Authors:  Hui-Ju Lin; Lei Wan; Fuu-Jen Tsai; Yi-Yu Tsai; Liuh-An Chen; Alicia Lishin Tsai; Yu-Chuen Huang
Journal:  BMC Ophthalmol       Date:  2014-03-31       Impact factor: 2.209

3.  Influence of Overnight Orthokeratology on Corneal Surface Shape and Optical Quality.

Authors:  Yuan Sun; Lin Wang; Jing Gao; Mei Yang; Qi Zhao
Journal:  J Ophthalmol       Date:  2017-10-01       Impact factor: 1.909

4.  Changes and Diurnal Variation of Visual Quality after Orthokeratology in Myopic Children.

Authors:  Hao-Chen Guo; Wan-Qing Jin; An-Peng Pan; Qin-Mei Wang; Jia Qu; A-Yong Yu
Journal:  J Ophthalmol       Date:  2018-10-15       Impact factor: 1.909

5.  The Topographical Effect of Optical Zone Diameter in Orthokeratology Contact Lenses in High Myopes.

Authors:  G Carracedo; T M Espinosa-Vidal; I Martínez-Alberquilla; L Batres
Journal:  J Ophthalmol       Date:  2019-01-02       Impact factor: 1.909

6.  A Deep Learning-Based Framework for Accurate Evaluation of Corneal Treatment Zone After Orthokeratology.

Authors:  Yong Tang; Zhao Chen; Weijia Wang; Longbo Wen; Linjing Zhou; Mao Wang; Fan Tang; He Tang; Weizhong Lan; Zhikuan Yang
Journal:  Transl Vis Sci Technol       Date:  2021-12-01       Impact factor: 3.283

7.  The associations of accommodation and aberrations in myopia control with orthokeratology.

Authors:  Chenglu Ding; Yunyun Chen; Xue Li; Yingying Huang; Hao Chen; Jinhua Bao
Journal:  Ophthalmic Physiol Opt       Date:  2021-12-05       Impact factor: 3.992

8.  Comparison of corneal irregular astigmatism by the type of corneal regular astigmatism.

Authors:  Yuta Ueno; Risa Nomura; Takahiro Hiraoka; Katsuhito Kinoshita; Mutsuko Ohara; Tetsuro Oshika
Journal:  Sci Rep       Date:  2021-08-04       Impact factor: 4.379

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.